| | |
| Egypt to look beyond U.S. for arms: foreign minister Saturday, Nov 02, 2013 05:46 PM PDT | Top |
| Tropical Depression churns toward Mexico's Pacific coast Saturday, Nov 02, 2013 03:22 PM PDT A tropical depression took aim at the Pacific coast of Mexico on Saturday, threatening heavy rains in a broad swath of western Mexico near the same area where other storms have caused major flooding over the past couple of months. Tropical depression Eighteen-E was churning over the Pacific Ocean 360 miles south of the resort city of Los Cabos at the southern tip of the Baja California peninsula and could become a tropical storm by Saturday night or Sunday, the Miami-based U.S. National Hurricane Center said. If the system becomes a tropical storm - with sustained winds of at least 39 mph - it will be called Sonia. Full Story | Top |
| Bristol seeks Japan approval of all-oral hepatitis C treatment Saturday, Nov 02, 2013 06:38 AM PDT Bristol-Myers Squibb Co has filed with Japanese health regulators seeking approval of its experimental all-oral combination of hepatitis C treatments, the U.S. drugmaker said on Saturday. The submission with Japan's Pharmaceutical and Medical Devices Agency marks the first time that any drugmaker has filed for approval of a hepatitis C treatment regimen that does not include either of the standard older treatments - the injected, difficult-to-tolerate interferon, or ribavirin, a pill. Gilead Sciences Inc, widely seen as the leader in a crowded race to develop highly effective, interferon-free treatments for the serious liver disease, has sought U.S. approval of its highly regarded anti-viral drug sofosbuvir in combination with ribavirin. A Food and Drug Administration advisory panel last week voted unanimously to recommend its approval. Full Story | Top |
| High cure rates seen with Merck oral hepatitis drugs: study Saturday, Nov 02, 2013 06:37 AM PDT A combination of two oral hepatitis C treatments developed by Merck & Co led to high cure rates in previously untreated patients, indicating the company is a contender in the race to find new treatments for the liver destroying virus. The treatments tested with and without the older drug ribavirin led to cure rates of 96 percent to 100 percent, according to interim data from a small midstage clinical trial. The results appear to confirm Merck will be competitive in the crowded race to develop interferon-free treatments for hepatitis C, assuming they are repeated in larger studies that include more difficult to treat patient populations, such as those not helped by prior therapy. Full Story | Top |
| Rousseff gives go-ahead to Brazil fuel price formula, Estado says Saturday, Nov 02, 2013 06:25 AM PDT | Top |
| Central Africa's central bank cuts rate as growth slows Saturday, Nov 02, 2013 03:48 AM PDT YAOUNDE (Reuters) - The central bank of the six-nation Central African CEMAC zone has cut its prime lending rate by 25 basis points to 3.25 percent to help spur the economy as it revised down its 2013 growth forecast to 2.6 percent from 4.1 percent. The bank's governor, Lucas Abaga Nchama, said in a statement late on Friday that the slow down in economic activity was due to a decline in public investments and oil production. The CEMAC zone is made up of Cameroon, Central African Republic, Chad, Congo-Brazzaville, Equatorial Guinea and Gabon. ... Full Story | Top |
| India asks IBM to pay $866 million in outstanding tax: reports Saturday, Nov 02, 2013 03:21 AM PDT | Top |
|

No comments:
Post a Comment